Apimeds Pharmaceuticals US (APUS) Files for 3.33M Share IPO at $3-$4/sh
Apimeds Pharmaceuticals US (NYSE: APUS) has filed for 3,333,334 share IPO at $3-$4 per share.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Morgan Stanley Upgrades Megaport Ltd. (MP1:AU) (MGPPF) to Overweight
- Blue Moon Metals cleared to build at Nevada tungsten project
Create E-mail Alert Related Categories
Corporate News, IPOsRelated Entities
IPO, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share